학술논문

Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness
Document Type
article
Source
Community Mental Health Journal. 59(2)
Subject
Brain Disorders
Clinical Research
Serious Mental Illness
Behavioral and Social Science
Mental Health
8.1 Organisation and delivery of services
Evaluation of treatments and therapeutic interventions
Health and social care services research
6.1 Pharmaceuticals
Management of diseases and conditions
7.1 Individual care needs
Mental health
Good Health and Well Being
Adult
Humans
Buprenorphine
Opiate Substitution Treatment
Opioid-Related Disorders
Analgesics
Opioid
Methadone
Mental disorders
Opioid use disorders
Opioid-related disorders
Narcotic antagonists
Buprenorphine-naloxone drug combination
Qualitative research
Clinical Sciences
Psychology
Psychiatry
Language
Abstract
Most people with co-occurring opioid use disorder (OUD) and mental illness do not receive effective medications for treating OUD. To investigate perspectives of adults in a publicly-funded mental health system regarding medications for OUD (MOUD), we conducted semi-structured telephone interviews with 13 adults with OUD (current or previous diagnosis) receiving mental health treatment. Themes that emerged included: perceiving or using MOUDs as a substitute for opioids or a temporary solution to prevent withdrawal symptoms; negative perceptions about methadone/methadone clinics; and viewing MOUD use as "cheating". Readiness to quit was important for patients to consider MOUDs. All participants were receptive to discussing MOUDs with their mental health providers and welcomed the convenience of receiving care for their mental health and OUD at the same location. In conclusion, clients at publicly-funded mental health clinics support MOUD treatment, signaling a need to expand access and build awareness of MOUDs in these settings.